The American Cancer Society’s Report on the Status of Cancer Disparities in the United States examines disparities in cancer occurrence and outcomes, and analyzes the factors that contribute to these ...

Investigators evaluated the benefit of leuprorelin immediately after radical prostatectomy for prostate cancer in patients ...

The Food and Drug Administration (FDA) has approved Breyanzi ® (lisocabtagene maraleucel; liso-cel) for the treatment of adult patients with relapsed or refractory (R/R) marginal zone lymphoma (MZL) ...

Investigators explored the association between baseline patient-reported fatigue and the risk adverse events in cancer ...

Subcutaneous administration takes less time and is tied to fewer administration-related reactions than intravenous.

Investigators reported extended 5-year follow-up data from the CheckMate 274 trial including exploratory MIBC and circulating tumor (ct)DNA data.

Although 76% respondents reported encountering medical misinformation, that exposure was not significantly associated with clinically significant fear of cancer recurrence or self-reported treatment ...

Socioeconomic status of cancer survivors or the neighborhood in which they live has a significant effect on their perceived work ability and functional outcomes.

Men are twice as likely as women to have stage III multiple myeloma at diagnosis and appear to have a greater tumor burden than women, according to ...

Noninferior five-year regional recurrence rates and regional recurrence-free survival reported with omission of SLNB.

In this study, researchers aimed to determine whether younger BRCA1/2 carriers who undergo oophorectomy can receive menopausal hormone therapy without increasing their risk of breast cancer.

A systematic review and meta-analysis compared the perioperative and oncologic outcomes of open versus minimally invasive inguinal lymphadenectomy during penile cancer surgery.